NSB logo

NeuroScientific Biopharmaceuticals Limited Stock Price

ASX:NSB Community·AU$46.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

NSB Share Price Performance

AU$0.14
0.10 (288.89%)
AU$0.14
0.10 (288.89%)
Price AU$0.14

NSB Community Narratives

There are no narratives available yet.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
0 Rewards

NeuroScientific Biopharmaceuticals Limited Key Details

AU$0

Revenue

-AU$473.0

Cost of Revenue

AU$473.0

Gross Profit

AU$1.8m

Other Expenses

-AU$1.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.0055
0%
0%
0%
View Full Analysis

About NSB

Founded
2002
Employees
n/a
CEO
Nathan Smith
WebsiteView website
neuroscientific.com

NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia.

Recent NSB News & Updates

NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) 117% Price Boost Is Out Of Tune With Earnings

Aug 01
NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) 117% Price Boost Is Out Of Tune With Earnings

Recent updates

No updates